Related Experiment Video
Updated: Mar 12, 2026
09:11
Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
Published on: January 23, 2009
12.3K
Advances in cell-based therapies for Peripheral arterial disease
1Regenerative Medicine, Geneva College Longevity Science, Geneva, Switzerland; Medical College, Health Sciences Academic Unit, University Center of Mineiros, Mineiros, Goias, Brazil.
Tissue & Cell
|March 10, 2026
Summary
Cell therapies show promise for critical limb ischemia (CLI) by aiding vascular regeneration, but inconsistent outcomes and manufacturing hurdles limit widespread use. Future success depends on standardized trials and regulatory harmonization.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Cell Therapy
Background:
- Peripheral arterial disease (PAD) impacts over 230 million globally, with critical limb ischemia (CLI) as its severe stage.
- Many CLI patients are ineligible for conventional treatments, necessitating novel therapeutic strategies.
- Cell-based therapies offer a regenerative approach to improve perfusion and prevent limb loss.
Purpose of the Study:
- To review the clinical translation of cell therapies for vascular regeneration in CLI and diabetic foot ulcers.
- To compare the efficacy, safety, and maturity of various cell sources.
- To identify barriers and potential solutions for clinical adoption.
Main Methods:
- Narrative review of clinical translation of cell therapies.
- Comparison of autologous bone marrow/adipose-derived mesenchymal stromal cells, umbilical cord cells, fetal progenitor cells, and iPSC-based platforms.
- Analysis of current clinical evidence on efficacy, safety, and mechanisms of action.
Main Results:
- Cell therapies demonstrate heterogeneous efficacy and favorable safety profiles, but inconsistent functional outcomes.
- Paracrine signaling, immunomodulation, and angiogenic factor secretion are key therapeutic mechanisms.
- Barriers include non-standardized manufacturing, lack of potency assays, regulatory fragmentation, and high costs.
Conclusions:
- Successful clinical translation requires harmonized regulations, rigorous trials, biomarkers, and sustainable reimbursement.
- Emerging innovations like biomaterials and exosomes need validation.
- Cell therapies currently remain experimental for highly selected populations.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
486
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
01:30Peripheral Artery Disease I: Introduction
521
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
569
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569
01:26Peripheral Artery Disease IV: Nursing Management
524
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
524
01:23Peripheral Artery Disease V: Postoperative Nursing Management
495
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
495
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K